Clinical application of MSC-Exos in ferroptosis The preclinical studies discussed throughout our review have shown promising results and hold great potential for future clinical applications
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases
Rating Submit a Review Product Citations publications IGF-I (insulin-like growth factor 1), initially described in 1957, is a hormone that is important in childhood growth and anabolic effects in adults
Tirzepatide activates GIP and GLP1 receptors to increase insulin, reduce glucagon, slow gastric emptying, and decrease appetite
Total weight loss at 48-68 weeks on the combination is difficult to predict without clinical trial data, but based on individual compound data (retatrutide at 24-28.7% and the additive benefit seen with CagriSema), a reasonable estimate for the combination is 25-35% total body weight reduction in high responders
Both carry risks of gastrointestinal side effects, pancreatitis, and contraindications in certain populations